VCR ventracor limited


  1. 423 Posts.
    Sydney, 22 March 2004: Ventracor Limited (ASX:VCR) today announced recent key management appointments as it works to rapidly commercialise its VentrAssist™ ‘artificial heart’ technology.

    Mr.Vanio Calgaro has been appointed Financial Controller. Mr. Calgaro is a Chartered Accountant with more than 17 years experience with Australian listed companies in the healthcare and biotechnology sector. Previously he was Financial Controller and Company Secretary with Peptech Limited (ASX: PTD).

    Mr. Victor Windeyer has been appointed VentrAssist™ Program Manager. He is working across all areas of the company to ensure Ventracor’s milestones are met. Mr. Windeyer has 10 years experience in development and manufacturing of precision medical and scientific equipment and was previously Program Manager of medical and scientific instruments at Invetech Pty Ltd.

    Mr. Roman Greifeneder has been appointed Manufacturing Engineering Manager. He is responsible for the rapid transition to large-scale manufacturing of devices for use in Ventracor’s expanding clinical trial program. He will also oversee validation of new manufacturing facilities currently nearing completion. Mr. Greifeneder has nine years medical device experience and was previously Manufacturing Engineering Manager with ResMed Limited (ASX: RMD).

    For more information, please contact:

    Andrew Geddes
    Manager, Investor Relations
    Ventracor Limited
    02 9406 3100
watchlist Created with Sketch. Add VCR (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.